DAPINELAT contains a medicine called nifedipine. This belongs to a group of medicines called calcium antagonists. DAPINELAT may be used to treat the following:
- high blood pressure or angina (chest pain)
DAPINELAT contains a medicine called nifedipine. This belongs to a group of medicines called calcium antagonists. DAPINELAT may be used to treat the following:
Do not take DAPINELAT:
Do not have this medicine if any of the above applies to you. If you are not sure, talk to your doctor, nurse or pharmacist before you are given DAPINELAT.
Do not break, bite or chew your tablets
Tell your doctor or health care provider before taking this medicine
Take special care with DAPINELAT:
How DAPINELAT is given
Do not share medicines prescribed for you with any other person. Always take DAPINELAT exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. DAPINELAT is specially formulated so that you only have to take one dose each day.
Dose for high blood pressure: the usual dose is 1 tablet, once a day.
Dose for angina: the dose depends on your individual requirements. Your doctor will decide how much you should take. Your doctor will tell you how long your treatment with DAPINELAT will last. Do not stop treatment early because. If you have the impression that the effect of DAPINELAT is too strong or too weak, tell your doctor or pharmacist.
The tablets should be swallowed whole with a glass of water, either with or without food. Taking your tablets at the same time each day will have the best effect on your blood pressure, preferably during the morning. It will also help you remember when to take the tablets, DAPINELAT must be swallowed whole; under no circumstances should they be bitten, chewed or broken up. Do not take them with grapefruit juice.
No dose adaptation in elderly people above 65 years is necessary.
No dosage adjustment is required in patients with kidney problems.
DAPINELAT is not recommended for use in children and adolescents below 18 years of age, because there are only limited data on the safety and efficacy in this population.
DAPINELAT should not be administered to patients with liver impairment.
If you missed a dose of DAPINELAT Do not take / receive a double dose to make up for forgotten individual doses. If you have any further questions on the use of this medicine, ask your doctor.
If you take more DAPINELAT than you should In the event of overdosage, consult your doctor or pharmacist. If neither is available, contact the nearest hospital or poison centre. Taking too many tablets may cause your blood pressure to become too low and your heartbeats to speed up or slow down. It may also lead to an increase in your blood sugar level or an increase in the acidity of your blood, swelling in the lungs, low blood oxygen levels and disturbances in consciousness, possibly leading to unconsciousness.
DAPINELAT can have side effects. Not all side effects reported for DAPINELAT are included in this leaflet. Should your general health worsen or if you experience any untoward effects while receiving this medicine, please consult your doctor, pharmacist or other healthcare professional for advice.
If any of the following happens, stop taking DAPINELAT and tell your doctor immediately or go to the casualty department at your nearest hospital:
Tell your doctor if you notice any of the following side effects.
If you notice any side effects not mentioned in this leaflet, please inform your doctor or pharmacist.
Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicine is important. It allows continued monitoring of the benefit/risk balance of the medicine. Health care providers are asked to report any suspected adverse reactions to SAHPRA via the “6.04 Adverse Drug Reactions Reporting Form”, found online under SAHPRA’s publications: https://www.sahpra.org.za/Publications/Index/8
Keep this medicine out of the sight and reach of children. Store at or below 25 °C. Not to be removed from the outer carton until required for use.
The Dapinelat professional information leaflet below is the property of Biotech Laboratories and is provided on Somayeza exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Somayeza serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
The patient information text is available above. Load the original PDF only when you need it.